Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells

Cellular Immunology

Volumn 287, Issue 2, 2014, Pages 100-105

  Wang, Quanrongzi ^a   Feng, Min ^b   Yu, Tongfu ^a   Liu, Xisheng ^a   Zhang, Peijian ^c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c YANGZHOU UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; IL 17; Matrix metalloproteases; Regulatory T cells

Indexed keywords

INTERLEUKIN 17; MESSENGER RNA; METALLOPROTEINASE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; BLOOD CULTURE; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL METASTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; MALE; METASTASIS; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

COLORECTAL CARCINOMA; IL-17; MATRIX METALLOPROTEASES; REGULATORY T CELLS;

ADULT; AGED; ANTIGENS, NEOPLASM; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERLEUKIN-17; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84893343007     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.01.002     Document Type: Article

References (26)

1. Liu J., Zhang N., Li Q., Zhang W., Ke F., Leng Q., Wang H., Chen J. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 2011, 6:e19495.
2. Betts G., Jones E., Junaid S., El-Shanawany T., Scurr M., Mizen P., Kumar M., Jones S., Rees B., Williams G., Gallimore A., Godkin A. Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut. 2012, 61:1163-1171.
3. Razmkhah M., Jaberipour M., Erfani N., Habibagahi M., Talei A.R., Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?. Cell Immunol. 2011, 266:116-122.
4. Li Y.Y., Chang J.W., Hsieh L.L., Yeh K.Y. Neutralization of interleukin (IL)-10 released by monocytes/macrophages enhances the up-regulatory effect of monocyte/macrophage-derived IL-6 on expressions of IL-6 and MUC1, and migration in HT-29 colon cancer cells. Cell Immunol. 2010, 265:164-171.
5. Kuang D.M., Peng C., Zhao Q., Wu Y., Zhu L.Y., Wang J., Yin X.Y., Li L., Zheng L. Tumor-activated monocytes promote expansion of IL-17-producing CD8+T cells in hepatocellular carcinoma patients. J. Immunol. 2010, 185:1544-1549.
6. Zhang J.P., Yan J., Xu J., Pang X.H., Chen M.S., Li L., Wu C., Li S.P., Zheng L. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 2009, 50:980-989.
7. Feng M., Li G., Qian X., Fan Y., Huang X., Zhang F., Lu L. IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion. Int. Immunopharmacol. 2012, 13:135-140.
8. Sharma A.K., LaPar D.J., Zhao Y., Li L., Lau C.L., Kron I.L., Iwakura Y., Okusa M.D., Laubach V.E. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am. J. Respir. Crit. Care Med. 2011, 183:1539-1549.
9. Hammerich L., Heymann F., Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin. Dev. Immunol. 2011, 2011:345803.
10. Feng M., Wang H., Wang Q., Guan W. Matrix metalloprotease 9 promotes liver recovery from ischemia and reperfusion injury. J. Surg Res. 2013, 180:156-161.
11. Bendardaf R., Lamlum H., Vihinen P., Ristamaki R., Laine J., Pyrhonen S. Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma. Oncology 2003, 65:337-346.
12. Buhmeida A., Bendardaf R., Hilska M., Collan Y., Laato M., Syrjanen S., Syrjanen K., Pyrhonen S. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma. J. Gastrointest. Cancer 2009, 40:91-97.
13. Feng W., Li W., Liu W., Wang F., Li Y., Yan W. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp. Mol. Pathol. 2009, 87:212-218.
14. Horwitz D.A., Zheng S.G., Gray J.D. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 2008, 29:429-435.
15. Lin J.Y., Tsai F.C., Wallace C.G., Huang W.C., Wei F.C., Liao S.K. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. J. Surg. Res. 2012, 178:974-981.
16. Feng M., Wang Q., Zhang F., Lu L. Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury. Int. Immunopharmacol. 2012, 12:189-196.
17. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., Zhang Z., Yang H., Zhang H., Zhou C., Yao J., Jin L., Wang H., Yang Y., Fu Y.X., Wang F.S. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
18. TrehanPati N., Kotillil S., Hissar S.S., Shrivastava S., Khanam A., Sukriti S., Mishra S.K., Sarin S.K. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate. J. Clin. Immunol. 2011, 31:509-520.
19. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005, 65:2457-2464.
20. Lee H.E., Park D.J., Kim W.H., Kim H.H., Lee H.S. High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer. Br. J. Cancer 2011, 105:413-419.
21. Loddenkemper C., Nagorsen D., Zeitz M. Foxp3 and microsatellite stability phenotype in colorectal cancer. Gut. 2008, 57:725-726.
22. Chaput N., Louafi S., Bardier A., Charlotte F., Vaillant J.C., Menegaux F., Rosenzwajg M., Lemoine F., Klatzmann D., Taieb J. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut. 2009, 58:520-529.
23. Chen K.J., Zhou L., Xie H.Y., Ahmed T.E., Feng X.W., Zheng S.S. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Med. Oncol. 2012, 29:1817-1826.
24. Wang Q., Yu T., Yuan Y., Zhuang H., Wang Z., Liu X., Feng M. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. J. Surg. Oncol. 2013, 107:422-427.
25. Kitani A., Xu L. Regulatory T cells and the induction of IL-17. Mucosal. Immunol. 2008, 1(Suppl 1):S43-46.
26. Tosolini M., Kirilovsky A., Mlecnik B., Fredriksen T., Mauger S., Bindea G., Berger A., Bruneval P., Fridman W.H., Pages F., Galon J. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 2011, 71:1263-1271.